A legal entity establishing and managing a repository used to verify the authenticity of or decommission the unique identifiers of medicinal products placed on the market in a Member State shall grant access to that repository and to the information contained therein, to competent authorities of that Member State for the following purposes:
supervising the functioning of the repositories and investigating potential incidents of falsification;
reimbursement;
pharmacovigilance or pharmacoepidemiology.